Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT

Sana Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-266.76M -283.25M -269.48M -355.93M
Depreciation & Amortization
17.39M 24.56M 15.63M 11.07M
Stock-Based Compensation
37.68M 35.53M 38.34M 22.36M
Other Working Capital
-2.56M 17.58M 6.48M 10.07M
Other Non-Cash Items
-10.28M -49.03M -82.08M 61.64M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.19M 18.61M 7.54M 9.8M
Operating Cash Flow
-223.15M -253.58M -290.05M -251.05M
Capital Expenditures
-33.43M -20.03M -20.88M -29.86M
Cash Acquisitions
n/a -192.04K -231.44K n/a
Purchase of Investments
n/a -157.74M -78.69M -491.39M
Sales Maturities Of Investments
n/a 349.79M 310.13M 280.02M
Other Investing Acitivies
17.45M 192.04K 231.44K -4.57M
Investing Cash Flow
17.45M 172.01M 210.56M -245.8M
Debt Repayment
7.74M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
11.01M n/a n/a n/a
Financial Cash Flow
199.75M 31.65M 4.91M 631.75M
Net Cash Flow
-5.95M -49.92M -74.58M 134.9M
Free Cash Flow
-256.58M -273.61M -310.93M -280.92M